Han Joan C, Liu Qing-Rong, Jones MaryPat, Levinn Rebecca L, Menzie Carolyn M, Jefferson-George Kyra S, Adler-Wailes Diane C, Sanford Ethan L, Lacbawan Felicitas L, Uhl George R, Rennert Owen M, Yanovski Jack A
Unit on Growth and Obesity, Program in Developmental Endocrinology and Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892-1103, USA.
N Engl J Med. 2008 Aug 28;359(9):918-27. doi: 10.1056/NEJMoa0801119.
Brain-derived neurotrophic factor (BDNF) has been found to be important in energy homeostasis in animal models, but little is known about its role in energy balance in humans. Heterozygous, variably sized, contiguous gene deletions causing haploinsufficiency of the WT1 and PAX6 genes on chromosome 11p13, approximately 4 Mb centromeric to BDNF (11p14.1), result in the Wilms' tumor, aniridia, genitourinary anomalies, and mental retardation (WAGR) syndrome. Hyperphagia and obesity were observed in a subgroup of patients with the WAGR syndrome. We hypothesized that the subphenotype of obesity in the WAGR syndrome is attributable to deletions that induce haploinsufficiency of BDNF.
We studied the relationship between genotype and body-mass index (BMI) in 33 patients with the WAGR syndrome who were recruited through the International WAGR Syndrome Association. The extent of each deletion was determined with the use of oligonucleotide comparative genomic hybridization.
Deletions of chromosome 11p in the patients studied ranged from 1.0 to 26.5 Mb; 58% of the patients had heterozygous BDNF deletions. These patients had significantly higher BMI z scores throughout childhood than did patients with intact BDNF (mean [+/-SD] z score at 8 to 10 years of age, 2.08+/-0.45 in patients with heterozygous BDNF deletions vs. 0.88+/-1.28 in patients without BDNF deletions; P=0.03). By 10 years of age, 100% of the patients with heterozygous BDNF deletions (95% confidence interval [CI], 77 to 100) were obese (BMI > or = 95th percentile for age and sex) as compared with 20% of persons without BDNF deletions (95% CI, 3 to 56; P<0.001). The critical region for childhood-onset obesity in the WAGR syndrome was located within 80 kb of exon 1 of BDNF. Serum BDNF concentrations were approximately 50% lower among the patients with heterozygous BDNF deletions (P=0.001).
Among persons with the WAGR syndrome, BDNF haploinsufficiency is associated with lower levels of serum BDNF and with childhood-onset obesity; thus, BDNF may be important for energy homeostasis in humans.
在动物模型中,脑源性神经营养因子(BDNF)已被发现对能量平衡很重要,但关于其在人类能量平衡中的作用却知之甚少。11号染色体短臂13区(11p13)上杂合的、大小可变的连续基因缺失导致WT1和PAX6基因单倍体不足,该区域位于BDNF(11p14.1)着丝粒约4 Mb处,会导致威尔姆斯瘤、无虹膜、泌尿生殖系统异常和智力发育迟缓(WAGR)综合征。在一部分WAGR综合征患者中观察到食欲亢进和肥胖。我们推测WAGR综合征中的肥胖亚表型归因于诱导BDNF单倍体不足的缺失。
我们研究了通过国际WAGR综合征协会招募的33例WAGR综合征患者的基因型与体重指数(BMI)之间的关系。使用寡核苷酸比较基因组杂交确定每个缺失的范围。
所研究患者的11号染色体短臂缺失范围为1.0至26.5 Mb;58%的患者存在杂合性BDNF缺失。这些患者在整个儿童期的BMI z评分显著高于BDNF完整的患者(8至10岁时的平均[±标准差]z评分,杂合性BDNF缺失患者为2.08±0.45,无BDNF缺失患者为0.88±1.28;P = 0.03)。到10岁时,100%的杂合性BDNF缺失患者(95%置信区间[CI],77至100)肥胖(BMI≥年龄和性别的第95百分位数),而无BDNF缺失者中这一比例为20%(95%CI,3至56;P<0.001)。WAGR综合征中儿童期肥胖的关键区域位于BDNF外显子1的80 kb范围内。杂合性BDNF缺失患者的血清BDNF浓度约低50%(P = 0.001)。
在WAGR综合征患者中,BDNF单倍体不足与血清BDNF水平降低和儿童期肥胖相关;因此,BDNF可能对人类的能量平衡很重要。